[1]
MOHAMED, A.A. et al. 2026. DESIGN, PHYSICOCHEMICAL CHARACTERIZATION, AND DEVELOPMENT OF A MATRIX DIFFUSION-CONTROLLED TRANSDERMAL PATCH OF RASAGILLINE FOR SUSTAINED ANTI-PARKINSON’S THERAPY. International Journal of Applied Pharmaceutics. 18, 2 (Mar. 2026), 190–199. DOI:https://doi.org/10.22159/ijap.2026v18i2.56843.